Suchergebnisse - "Sarilumab"

PubPharm (8)

1

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis : results from post hoc analyses of three phase III trials of sarilumab

enthalten in: Arthritis research & therapy | 2022

von Rubbert-Roth, A. | Furst, D. | Fiore, S. | +5

2

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

enthalten in: Arthritis research & therapy | 2020

von Strand, V. | Boklage, S. | Kimura, T. | +3

3

Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies

enthalten in: Arthritis research & therapy | 2020

von Genovese, M. | Fleischmann, R. | Kivitz, A. | +6

4

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

enthalten in: Arthritis research & therapy | 2020

von Gabay, C. | Burmester, G. | Strand, V. | +8

5

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate : results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis research & therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

ErratumIn: Arthritis Res Ther. 2019 Apr 16;21(1):99. - PMID 30992058

6

Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis

enthalten in: Arthritis research & therapy | 2018

von Strand, V. | Gossec, L. | Proudfoot, C. | +9

7

Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate : a biomarker study of MOBILITY

enthalten in: Arthritis research & therapy | 2016

von Boyapati, A. | Msihid, J. | Fiore, S. | +3

8

Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate : results of a phase III trial

enthalten in: Arthritis research & therapy | 2016

von Strand, V. | Kosinski, M. | Chen, C. | +8

1
[1]